A Lens for Evaluating Genetic Information Governance Models: Balancing Equity, Efficiency and Sustainability by Skorve, Espen et al.
   
 
Aalborg Universitet
A Lens for Evaluating Genetic Information Governance Models
Skorve, Espen; Vassilakopoulou, Polyxeni; Aanestad, Margunn; Grünfeld, Thomas
Published in:
Informatics for Health
DOI (link to publication from Publisher):
10.3233/978-1-61499-753-5-298
Creative Commons License
CC BY-NC 4.0
Publication date:
2017
Document Version
Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Skorve, E., Vassilakopoulou, P., Aanestad, M., & Grünfeld, T. (2017). A Lens for Evaluating Genetic Information
Governance Models: Balancing Equity, Efficiency and Sustainability. In . R. Randell, R. Cornet, C. McCowan, N.
Peek, & P. J. Scott (Eds.), Informatics for Health: Connected Citizen-Led Wellness and Population Health (pp.
298-302). IOS Press.  Studies in Health Technology and Informatics, Vol.. 235, DOI: 10.3233/978-1-61499-753-
5-298
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to
the work immediately and investigate your claim.
Downloaded from vbn.aau.dk on: februar 15, 2018
A Lens for Evaluating Genetic Information 
Governance Models: Balancing Equity, 
Efficiency and Sustainability 
Espen SKORVEa,1, Polyxeni VASSILAKOPOULOUb, Margunn AANESTADc, 
Thomas GRÜNFELDd 
a
 Aalborg University, Denmark 
bUniversity of Agder, Norway 
cUniversity of Oslo, Norway 
dOslo University Hospital, Norway 
Abstract. This paper draws from the literature on collective action and the 
governance of the commons to address the governance of genetic data on variants 
of specific genes. Specifically, the data arrangements under study relate to the 
BRCA genes (BRCA1 and BRCA2) which are linked to breast and ovarian cancer. 
These data are stored in global genetic data repositories and accessed by 
researchers and clinicians, from both public and private institutions. The current 
BRCA data arrangements are fragmented and politicized as there are multiple 
tensions around data ownership and sharing. Three key principles are proposed for 
forming and evaluating data governance arrangements in the field. These 
principles are: equity, efficiency and sustainability.  
Keywords. Genetic information, governance, the commons. 
1. Introduction 
The significance of genetic testing for clinical purposes is increasing, and the rapid 
advances in sequencing technologies are currently amplifying this development. One 
outcome of this is the exponential growth in genetic data generation. New data are 
continuously produced as output of genetic analyses performed all over the world. The 
new data are subsequently used as an essential input for further analyses for research 
and clinical purposes alike. In this paper, we focus on data related to the (potential) 
pathogenicity of variants of specific genes. These data relate to single genes, they are 
completely anonymous, and do not raise any privacy issues. They are valuable for 
taking clinical decisions related to diagnostics, treatments and prevention [1][2][3]. 
Their importance for decision taking is making it urgent to address data governance in 
the domain addressing the tensions, contestations and controversies around data 
ownership and control. These tensions are shaping the currently fragmented and 
politicized landscape of gene-specific data repositories. The current situation is making 
it difficult to reap the benefits of the increased speed and reduced cost associated with 
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new sequencing technologies [4][5]. In order to address this issue, we need a 
perspective that can be conducive to reaching resolutions within such a complex 
domain. In this paper, we draw from theoretical resources on “the commons” that can 
be used as a basis for resolving governance issues and for facilitating a sustainable 
development within the field. 
We turn to the theory of the commons [6][7] aiming to draw concepts for 
addressing “the age-old problem of how to induce collaborative problem solving and 
other forms of collective action among self-interested individuals, groups, or 
organizations, assuming, of course, that they share at least some common goals” [8]. In 
this body of literature, a basic assumption is that different types of resources are subject 
to different governance considerations, and a common taxonomy for discussing this is 
drawn along the axis of subtractability and exclusion [9] [10]. Based on a claim that 
knowledge about the human genome belongs to mankind as a whole, current attempts 
at privatizing data that can contribute to this knowledge have been characterized as a 
second enclosure movement [11]2. We argue that biomedical knowledge in general, 
and genetic knowledge in particular, is of such a character that it constitutes what we 
call a public good. Hence, we adopt three fundamental concepts for evaluating any 
regime aiming to govern data that can contribute this knowledge resource: equity, 
efficiency and sustainability [10]. 
2. Case Background and Method 
A typical example of the genetic data governance challenges can be found in the 
specialized field of breast cancer genetics, and the way this has evolved over the two 
decades that passed since the identification of the BRCA genes. The BRCA genes 
(BRCA1 and BRCA2) are related to susceptibility to breast and ovarian cancer. Multiple 
data repositories containing information regarding the pathogenicity associated with 
specific variants of these two genes have emerged during that past decades. A main 
distinction between these repositories is how contribution and access rights are 
organized and governed, and their differences are most often related to the degree of 
openness. The Breast Cancer Information Core (BIC) was the first open access 
repository of BRCA data (it was established in 1995). This is a shared repository where 
information generated from research or clinical practice, within private and public 
laboratories all over the world can be deposited and retrieved. In the U.S.A, one private 
laboratory (Myriad Laboratories) was able to establish a dominant position in the local 
market for BRCA testing after having been granted several patents based on its central 
role in the discovery of the BRCA genes. This laboratory was the primary contributor to 
the BIC database for several years, and the ‘BRCA community’ was fairly dependent on 
Myriad’s sharing of knowledge and information. When Myriad decided to discontinue 
their contributions to BIC in 2004, this was therefore a major event that caused several 
counter actions aimed at amending the problems arising from significant information 
being disclosed from the community. Through initiatives like the ‘Sharing Clinical 
Reports’ and ‘Free the Data’ projects, new open access repositories were established, 
and doctors and patients were encouraged to register the detailed results from their lab 
tests at Myriad’s [12][13]. Furthermore, several other initiatives have emerged on both 
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sides of the Atlantic. The Leiden University Medical Center (Netherlands) launched 
‘LOVD’ as early as 2005, and ‘ClinVar’ was released by the US National Center for 
Biotechnology Information (NCBI) in 2012. In 2015, the ‘BRCA Mutation Database’ 
(by the University of Utah’s Department of Pathology and the ARUP Laboratories. 
USA), the ‘BRCA Share’ repository (INSERM and Quest Diagnostics, France) and the 
repository ‘BRCA Exchange’ (by the Global Alliance for Genomics and Health) were 
launched. The latter is particularly interesting, as it constitutes a global, networked 
initiative (as indicated by the name), and thus most strongly manifests the general 
tendency of initiatives the span the boundaries of single, local or even national actors. 
However, this increasing multiplicity of repositories and initiatives in the domain 
results in duplication of efforts and increased difficulty in data retrieval.  
The research reported in this paper is designed as a case study [14] with focus on 
the shaping of governance arrangements for information related to the (potential) 
pathogenicity of BRCA variants. We collected empirical material over a two years´ 
period as part of the activities of a research and development project that aimed to 
develop a secure IT platform to facilitate distributed collaboration and access to genetic 
information.  We performed 12 interviews with experts in the domain and we reviewed 
more than 100 documents (journal papers, specialised press reports, commercial 
announcements) to identify key events that mark the evolution of governance 
arrangements in BRCA domain. We adopted an interpretive approach for the analysis 
of the data [15] going through transcripts, notes and documents in order to identify 
relevant themes. We structured our analysis around the key theoretical concepts of 
equity, efficiency and sustainability. Initial findings were refined and verified based on 
continuous communications with practitioners in the field of genetic analysis. 
3. Addressing Information Governance Based on a Commons Perspective 
3.1. Equity 
Any public good is subject to some sort of distribution of rights and obligations 
amongst its stakeholders. Who does the work related to growth and maintenance, and 
who gets to benefit from what the resource has to offer? Is the resource available to 
those who need it, where and when they need it? Whose voices are heard when 
decisions are made that affect larger parts of the stakeholder community? Indeed, the 
question of who is considered to have a legit stake is in itself an important question in 
the context of a public good resource. While basic democratic values are obviously 
relevant, these issues are also pivotal in ensuring a wide commitment when few 
sanctions are available to force adherence to a common governance regime. The 
knowledge produced in the Myriad Laboratories is built on – and thus inherently part 
of – the global body of scientific knowledge about human genetic variations and their 
clinical significance. When they refuse to share their data that can contribute to further 
advancing the knowledge, they breach the commons´ logic. The community’s response 
to Myriads enclosure policy is a reaction to the perceived inequity in the distribution of 
benefits (enclosure means that one key actor can reap disproportionally more benefits) 
and incurred costs (the generation of valuable data today is built upon the accumulated 
efforts and resources invested for many decades around the world). 
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3.2. Efficiency 
For a governance arrangement to reach widespread support, it must provide an 
acceptable level of resource access and quality, at an acceptable cost, to members of the 
community. An inefficient arrangement will inevitably create a sense of a non-working 
system that might undermine its legitimacy and subsequent support. A particular 
challenging aspect of this is aligning, or balancing potentially diverse – and sometimes 
contradictory – values and requirements amongst different stakeholder groups. For 
instance, while uncertainty related to the clinical significance of a genetic variant is 
problematic for clinicians, it might represent a potential research question for the 
researchers. An efficient governance regime will have to make sure that such issues are 
reflected in the knowledge resource and its representations when possible. 
3.3. Sustainability 
Though a knowledge resource cannot be depleted, its long-term trajectory is normally 
subject to considerable dynamics. For a relatively novel field such as that of human 
genetic variants, the creation and addition of new knowledge is a main part of the 
dynamics. The evolution of knowledge and technology mutually drive each other. How 
can access, quality and costs be maintained within acceptable limits in this context of 
rapid change? In what direction is the trajectory moving and what are the issues driving 
and hampering its development? As new knowledge is primarily built on existing 
knowledge, an enclosure policy represents a potential threat to sustainability. Single 
actors growing too dominant can also undermine the community’s trust and 
commitment, which in turn can jeopardise a responsible long term development. In the 
field of genetic knowledge, the continuous addition of new actors and their 
contributions and requirements is also an aspect that must be catered for in a long term 
perspective. 
4. Concluding Remarks 
The commons perspective advocates governance arrangements that favour the 
community as a whole while still allowing single stakeholders or groups of 
stakeholders to pursue their own interests. The ever increasing complexity related to 
the formation, maintenance and propagation of genetic and other biomedical 
knowledge will inevitably force the emergence of such arrangements. Fulk et al. 
explore the role of connective and communal public goods in discretionary repositories 
[8]. Information is discussed there as a hybrid (neither private nor public) good, where 
public benefit is achieved by individuals or companies acting out of their private 
interests. In the case discussed here the balancing of private interests is still in flux and 
this creates tensions for sustaining the discretionary repositories. It is our contention 
that a level of abstraction, where the various stakeholders can reach a common 
understanding and a shared goal, is a prerequisite for establishing a working 
governance regime. Based on the commons perspective, we have suggested equity, 
efficiency and sustainability as such an abstraction. As key principles, they may serve 
as a platform for translations and operationalisations into governance arrangements that 
will work for the community they are supposed to serve. 
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